Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn
Biogen will sell its equity stake in the biosimilars joint venture to Samsung Biologics for up to $2.3bn.
Archives for January 28, 2022
Cryoport and Cell Matters team up on cryopreservation services
Cryoport, Inc. has entered into a partnership with specialized Belgian CDMO, Cell Matters, to deliver end-to-end cryopreservation services for leukapheresis derived therapies supporting both autologous and allogeneic cell therapies.
Recipharm leverages BSF capabilities at French site, secures vaccine packaging deal
Contract development and manufacturing organization (CDMO), Recipharm, says it has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.
Gilead backed Kyverna Therapeutics closes $85m Series B financing round
Kyverna Therapeutics, a cell therapy company engineering a new class of therapies for autoimmune diseases, has closed an oversubscribed $85m Series B financing round led by Northpond Ventures.